Dr. David Bajor, M.D.
Claim this profileUniversity Hospitals Cleveland Medical Center
Studies Pancreatic Cancer
Studies Cancer
11 reported clinical trials
22 drugs studied
Area of expertise
1Pancreatic Cancer
Stage III
Stage IV
2Cancer
Stage IV
Stage III
PIK3CA positive
Affiliated Hospitals
Clinical Trials David Bajor, M.D. is currently running
TOS-358
for Cancer
This trial tests TOS-358, a new drug for adults with specific cancers that have a genetic mutation. It aims to find the safest dose and see how well patients tolerate it. The drug works by blocking a gene that helps cancer cells grow.
Recruiting1 award Phase 1
SGN-EGFRd2
for Advanced Cancer
This study will test the safety of a drug called SGN-EGFRd2 in participants with advanced solid tumors. It will also study the side effects of this drug. A side effect is anything a drug does to the body besides treating the disease. Participants will have cancer that cannot be removed (unresectable) or has spread through the body (metastatic). This study will have three parts. Parts A and B of the study will find out how much SGN-EGFRd2 should be given to participants. Part C will use the dose found in parts A and B to find out how safe SGN-EGFRd2 is and if it works to treat solid tumor cancers.
Recruiting1 award Phase 13 criteria
More about David Bajor, M.D.
Clinical Trial Related4 years of experience running clinical trials · Led 11 trials as a Principal Investigator · 7 Active Clinical TrialsTreatments David Bajor, M.D. has experience with
- CPI-613
- Cisplatin
- Oxaliplatin
- TSR-022
- Gemcitabine
- Ivosidenib
Breakdown of trials David Bajor, M.D. has run
Pancreatic Cancer
Cancer
Tumors
Squamous Cell Carcinoma
Colorectal Cancer
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does David Bajor, M.D. specialize in?
David Bajor, M.D. focuses on Pancreatic Cancer and Cancer. In particular, much of their work with Pancreatic Cancer has involved Stage III patients, or patients who are Stage IV.
Is David Bajor, M.D. currently recruiting for clinical trials?
Yes, David Bajor, M.D. is currently recruiting for 7 clinical trials in Cleveland Ohio. If you're interested in participating, you should apply.
Are there any treatments that David Bajor, M.D. has studied deeply?
Yes, David Bajor, M.D. has studied treatments such as CPI-613, Cisplatin, Oxaliplatin.
What is the best way to schedule an appointment with David Bajor, M.D.?
Apply for one of the trials that David Bajor, M.D. is conducting.
What is the office address of David Bajor, M.D.?
The office of David Bajor, M.D. is located at: University Hospitals Cleveland Medical Center, Cleveland, Ohio 44106 United States. This is the address for their practice at the University Hospitals Cleveland Medical Center.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.